Next Article in Journal
The Use and Effectiveness of Temozolomide in Children with Central Nervous System Tumours: A Survey from the Canadian Paediatric Brain Tumour Consortium
Previous Article in Journal
Knowledge Translation to Improve Cancer Control in Canada: A New Standing Series in Current Oncology
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Comparative Analysis of Monthly Out-of-Pocket Costs for Patients with Breast Cancer as Compared with Other Common Cancers in Ontario, Canada

by
Christopher J. Longo
1,* and
B. G. Bereza
2
1
DeGroote School of Business and Centre for Health Economics and Policy Analysis, Mc- Master University, Hamilton, and Dalla Lana School of Public Health, University of Toronto, Toronto, ON L8S 4M4, Canada
2
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2011, 18(1), 681; https://doi.org/10.3747/co.v18i1.681
Submission received: 9 November 2010 / Revised: 8 December 2010 / Accepted: 5 January 2011 / Published: 1 February 2011

Abstract

Background: Monthly out-of-pocket costs (OOPC) for Ontario patients with cancer have previously been reported, but little detail has been provided on differences based on tumour type. Methods: A questionnaire administered in cancer clinics in the province of Ontario, with a mix of urban and rural patients, was analyzed using descriptive statistics and a regression analysis of cross-sectional data. The dependent variable was OOPC (Canadian dollars), analyzed separately for total OOPC (excluding imputed travel costs), and for each of the individual cost categories. Results: Compared with colorectal, lung, and prostate cancer patients combined, breast cancer patients had statistically significantly higher total OOPC ($393 vs. $149, p = 0.02), device costs ($142 vs. $12, p = 0.018), and family care costs ($38 vs. $3, p = 0.01). By contrast, they trended toward lower costs for travel ($225 vs. $426, p = 0.055) and had lower costs for parking ($32 vs. $53, p = 0.0198). Compared with non-breast cancer patients, patients with breast cancer reported a greater perceived financial burden (31% vs. 17% p = 0.0133). Interpretation: These findings highlight that financial burden for cancer patients can vary by tumour type, and that patients with breast cancer may require a different mix of supportive services than do patients with other common tumour types. Supportive care programs related to financial burden should consider the likelihood and nature of financial burden when counselling breast cancer patients.
Keywords: breast cancer; out-of-pocket costs; self-administered questionnaire; health care funding breast cancer; out-of-pocket costs; self-administered questionnaire; health care funding

Share and Cite

MDPI and ACS Style

Longo, C.J.; Bereza, B.G. A Comparative Analysis of Monthly Out-of-Pocket Costs for Patients with Breast Cancer as Compared with Other Common Cancers in Ontario, Canada. Curr. Oncol. 2011, 18, 681. https://doi.org/10.3747/co.v18i1.681

AMA Style

Longo CJ, Bereza BG. A Comparative Analysis of Monthly Out-of-Pocket Costs for Patients with Breast Cancer as Compared with Other Common Cancers in Ontario, Canada. Current Oncology. 2011; 18(1):681. https://doi.org/10.3747/co.v18i1.681

Chicago/Turabian Style

Longo, Christopher J., and B. G. Bereza. 2011. "A Comparative Analysis of Monthly Out-of-Pocket Costs for Patients with Breast Cancer as Compared with Other Common Cancers in Ontario, Canada" Current Oncology 18, no. 1: 681. https://doi.org/10.3747/co.v18i1.681

APA Style

Longo, C. J., & Bereza, B. G. (2011). A Comparative Analysis of Monthly Out-of-Pocket Costs for Patients with Breast Cancer as Compared with Other Common Cancers in Ontario, Canada. Current Oncology, 18(1), 681. https://doi.org/10.3747/co.v18i1.681

Article Metrics

Back to TopTop